OpenAI Acquires Biotech Startup Orchestra Bio to Strengthen Its Biotech Business
Ai Focus
On Tuesday, OpenAI acquired Orchestra Bio, a four-year-old biotech software startup founded by AI. The terms of the transaction were not disclosed. It was previously reported that the company had raised approximately $20 million from investors such as Andreessen Horowitz, Atria, and 8VC.
OpenAI acquired on Tuesday the four-year-old AI biotech software startup Orchestra Bio. The company announced this news through its website.
The transaction terms have not been disclosed, but it is reported that as of 2025, the startup has raised approximately $20 million from investors such as Andreessen Horowitz, Atria, and 8VC.
Orchestra develops AI agents to assist biotech companies in managing the mundane tasks of drug discovery operations, ranging from tracking finances to resolving scheduling issues for clinical trials.
This acquisition is a typical example of how the largest AI laboratories – particularly OpenAI and Anthropic – are developing an increasing amount of software for major industries such as pharmaceuticals. Within the startup community, there has always been concern that AI laboratories might introduce new features at any time and become competitors. In this case, Orchestra was absorbed, rather than being defeated.
Follow HQYC official accounts to stay updated
Views 14
HQYC reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”，and we will handle it promptly。
No comments yet. Be the first!
Stellar's Bell Protocol 30-level upgraded intelligent accountThe Bell Protocol 30 upgrade of Stellar will focus on smart accounts for enterprise use. According to a post on the X platform by Stellar, related work will begin on developing quantum-resistant signatures and faster ledgers; the original source states that this upgrade aims to incorporate these features and improve ledger speed. The upgrade plan will first go live on the test network on November 3, followed by its launch on the mainnet on November 23.
The Cryptonomist
·2026-10-21 05:22:434 
Optimum's mump2p protocol accelerates Ethereum block propagationOptimum indicates that its mump2p protocol was launched on the mainnet on October 20, 2026, adding a parallel path for Ethereum block propagation, claiming that its block transmission speed is 2.42 times faster than that of the default network. Optimum also states that 16 node operators are already running this software, including all 12 operators in the ether.fi validator set, and the adoption of this software has become a mandatory requirement within that set.
The Cryptonomist
·2026-10-21 05:22:413 
GPT-6 Demonstrates Remaining Programming Skills; OpenAI Makes Improvements on COBOLOpenAI indicates that GPT-6 has improved its capabilities in legacy programming languages such as COBOL, Fortran, and Visual Basic, and has made progress in two evaluations. The disclosed results include: GPT-6 Astra achieved an average test pass rate of 87.4% across 20 programming languages, and GPT-6.1 Sol had an accuracy rate of 97.9% on the COBOL migration benchmark.
The Cryptonomist
·2026-10-21 05:22:394 
Braze stock price reports $45.545, up 51.61% from the previous closeAs of 12:53 Eastern Time on Tuesday, the stock price of Braze was reported at $45.545, up 51.61% from the previous trading day's close. The article states that after Salesforce announced its intention to acquire Braze through a cash transaction, the stock price soared significantly; technically, both the daily and hourly charts show bullish patterns, but RSI on multiple time frames has entered an overbought zone, complicating the judgment of whether the short-term upward trend will continue.
The Cryptonomist
·2026-10-21 05:22:375 
Fortune
·2026-10-21 05:02:069 View More
